Drug Trial Radar · NCT07205900
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: Apr 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
267
Actual
Start
Dec 2, 2025
Primary completion
Jan 2027
Study completion Jan 2027
Sponsor
- Lead sponsor
- Hanmi Pharmaceutical Company LimitedIndustry
- Sponsor type
- Industry
- First posted
- Oct 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Study is a Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus.
Conditions
- Obese
- Obesity
Interventions
HM15275Drug
HM15275 is a sterile solution for subcutaneous injection, supplied pre-filled syringes.
Placebo of HM15275Drug
A sterile, matching solution supplied in pre-filled syringes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Body Weight.Time frame: Up to 41 weeks
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
ProSciento Inc
Chula Vista, California
Accellacare of Duly - Duly Oak Lawn
Oak Lawn, Illinois
Accellacare of McFarland
Ames, Iowa
Accellacare of Cary - Cary Medical Group
Cary, North Carolina
Accellacare of Hickory
Hickory, North Carolina
Raleigh Medical Group, P.A.
Raleigh, North Carolina
Accellacare of Piedmont - Piedmont HealthCare
Statesville, North Carolina
Accellacare of Wilmington, LLC
Wilmington, North Carolina
Accellacare of Winston Salem
Winston-Salem, North Carolina
Accellacare of Charleston
Mt. Pleasant, South Carolina
Accellacare of Bristol-PAC of Tennessee
Bristol, Tennessee
Bristol-Internal Medicine and Pediatric Associates of Bristol, P.C.
Bristol, Tennessee
Texas Clinical Research Institute
Arlington, Texas
Velocity Clinical Research, Dallas
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.